Norway· NO-ID_8569F0CA-7C86-45DB-B40E-DDEE030C0D6F
Cefalotin VM navamedic SA
A cefalotin product containing cefalotin, registered in Norway by Sykehusapoteket Ahus, Lørenskog. The same ATC class is registered in 3 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Cefalotin is registered in 3 of 19 countries.
Countries holding a registration under ATC J01DB03 (cefalotin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 2 of them publish a price we can compare per daily dose
Cefalotin · ATC J01DB03
3 / 19 countries
- Finlandprice
- Japan
- Norwayprice
The record
At a glance
FEST (Norway)- Active substance
- Cefalotin
- Manufacturer
- Sykehusapoteket Ahus, Lørenskog
- Country
- Norway (NO)
- ATC code
- J01DB03
- ATC class
- Cefalotin
- Defined daily dose
- 4 g, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_8569F0CA-7C86-45DB-B40E-DDEE030C0D6F
- no_varenummer24215710 x 2
- gtin7072279019383
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
19 interactions on record for cefalotin.
Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefalotin · interactions on record
19 records
- 19 moderate
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefalotin in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- France · Cefalotine Panpharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/995ff82b-d3f1-4a33-9926-90ed7a020c75 GET /v1/drugs/995ff82b-d3f1-4a33-9926-90ed7a020c75?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver og væske til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Cefalotin",
"merkevare_id": "ID_8569F0CA-7C86-45DB-B40E-DDEE030C0D6F",
"name_form_strength": "Cefalotin VM navamedic SA pulv+væske til inf oppl 2 g",
"prescription_group": "C"
}See everything about cefalotin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.